Security key
15117F807
Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)
CUSIP: 15117F807
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common stock, par value $0.00001
- Total 13F shares
- 56,000
- Total 13F value
- $23,000
- Share change
- +56,000
- SEC-reported price per share
- $0.41
- Number of holders
- 1
- Value change
- +$23,000
- Number of buys
- 1
- Shares outstanding
- 43,754,363
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
1
Top holders
1
CLRB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F807
Recent filing periods:
Ownership snapshot
Top reported holders of CLRB - Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
AIGH Capital Management LLC
Disclosed value leader
AIGH Capital Management LLC
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 21%
Showing 1-6 of 15 holder rows.
Quick read
AIGH Capital Management LLC leads the comparable SEC ownership view at 21%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens AIGH Capital Management LLC's linked filing trail.
Comparable ownership
Top 5
AIGH Capital Management LLC
21%
VANGUARD GROUP INC
20%
BlackRock Finance, Inc.
8.2%
Worth Venture Partners, LLC
5.3%
GEODE CAPITAL MANAGEMENT, LLC
5.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
Company
|
21%
|
$1,263,000
1,837,046 shares
|
— | 31 Mar 2022 |
| VANGUARD GROUP INC |
13F
Company
|
20%
|
$1,206,000
1,753,800 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
8.2%
|
$489,000
712,679 shares
|
— | 31 Mar 2022 |
| Worth Venture Partners, LLC |
13F
Company
|
5.3%
|
$315,000
458,245 shares
|
— | 31 Mar 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
5.1%
|
$303,000
441,883 shares
|
— | 31 Mar 2022 |
| Maven Securities LTD |
13F
Company
|
4.6%
|
$275,000
400,000 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
56,000
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2022 holders
1
Holder diff
0
| Investor | Q3 2025 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend